Most causal genes underwent CNV in glioma samples, with AS3MT, DNA2, and SCDF1 being predominantly heterozygous deletion, while RASA4 and EGFR were predominantly heterozygous and homozygous amplification. This evidence concerns the gene EGFR and central nervous system cancer.